Comparison of Cutting Balloon Angioplasty and Percutaneous Balloon Angioplasty of Arteriovenous Fistula Stenosis: A Meta‐Analysis and Systematic Review of Randomized Clinical Trials
- 20 May 2015
- journal article
- research article
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 28 (3) , 288-295
Abstract
Background: Hemodialysis (HD) access failure is a common cause of increased morbidity and healthcare cost in patients with end stage renal disease (ESRD). Percutaneous balloon angioplasty has been used to treat hemodialysis access stenosis but is complicated by a high rate of restenosis. Percutaneous cutting balloon (PCB) angioplasty is an alternative approach that has shown to reduce restenosis.Objectives: The aim of the study is to assess the safety and efficacy of PCB angioplasty in comparison with conventional and high‐pressure balloon angioplasty in the treatment of hemodialysis access site stenosis.Methods: We searched PubMed, EMBASE and the Cochrane Central register of controlled trials (CENTRAL) databases through August 2014 and selected studies using the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) checklist. We included all randomized clinical trials with a head‐to‐head comparison between PCB and conventional or high‐pressure balloon angioplastyResults: Three studies with 1034 participants (age 60.7 (±12.9) years and 50.1% males) with 525 in PCB and 509 in control arm were included in the analysis. The immediate procedural success rate was not significantly different in the PCB angioplasty and control arm respectively, (87.2% vs. 83.7% RD −0.02; 95%CI −0.06 to 0.01; P = 0.38). The six‐month target lesion patency was significantly higher in the PCB angioplasty arm (67.2% vs. 55.6% RD 0.12; 95%CI 0.05–0.19; P < 0.05) with number needed to treat (NNT) of 9. The device related complications were not statistically significant between groups (RD 0.03; 95%CI −0.02 to 0.07; P = 0.26).Conclusions: PCB angioplasty is effective in treatment of hemodialysis access stenosis, with significantly higher six‐month patency compared to balloon angioplasty. (J Interven Cardiol 2015;28:288–295)Keywords
This publication has 22 references indexed in Scilit:
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Ultrahigh-Pressure Angioplasty versus the Peripheral Cutting Balloon™ for Treatment of Stenoses in Autogenous Fistulas: Comparison of Immediate ResultsThe Journal of Vascular Access, 2010
- Cutting balloon angioplasty for resistant venous stenoses of dialysis access: Immediate and patency resultsCatheterization and Cardiovascular Interventions, 2008
- Hemodialysis Vascular Access DysfunctionJournal of the American Society of Nephrology, 2006
- Radiocephalic Wrist Arteriovenous Fistula for Hemodialysis: Meta-analysis Indicates a High Primary Failure RateEuropean Journal of Vascular and Endovascular Surgery, 2004
- American Society of Diagnostic and Interventional Nephrology Section Editor: Stephen Ash: Cutting Balloon Angioplasty for Resistant Venous Anastomotic StenosesSeminars in Dialysis, 2004
- Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosisJACC, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Cutting balloon: A novel approach to percutaneous angioplastyThe American Journal of Cardiology, 1991